Aurora Cannabis Inc (ACB) stock
ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$4.52−0.09 (-1.95%)
Close on Nov 17, 2026Market cap $266.44MP/E –Yield –
Aurora Cannabis r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2026 it was C$4.02M, up 9.4% from the year before. The highest annual figure on record is C$26.03M in fiscal 2020.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | C$4.02M | +9.4% |
| FY2025 | Mar 31, 2025 | C$3.68M | -64.6% |
| FY2022 | Jun 30, 2022 | C$10.39M | -9.2% |
| FY2021 | Jun 30, 2021 | C$11.45M | -56.0% |
| FY2020 | Jun 30, 2020 | C$26.03M | +76.1% |
| FY2019 | Jun 30, 2019 | C$14.78M | +780.2% |
| FY2018 | Jun 30, 2018 | C$1.68M | – |
See a number that looks wrong?